Novo Nordisk

Novo Nordisk is a company.

Filter

All

Business

Culture

Environment

Health

Politics

Research

Key facts

Country: Germany
Sector: Health Care
Industry: Pharmaceuticals

Website

Twitter: 47K

LinkedIn: 1M

Latest news (see all)

Novo Nordisk beats Q1 estimates as weight-loss drugs drive growth

Read: Euronews

2024-05-02

Weight-loss drug maker Novo Nordisk's profits soar further

Read: The Local

2024-05-02

Inside Novo Nordisk, the Company Behind Ozempic and Wegovy

Read: The New York Times

2024-04-20

Sanders calls for Novo Nordisk to slash Ozempic, Wegovy prices

Read: The Hill

2024-03-27

Ozempic maker Novo Nordisk gets more weight loss drug competition as a rival releases promising data

Read: Quartz

2024-03-26

Novo Nordisk to Expand Cardio Push with German Buy

Read: The Wall Street Journal

2024-03-25

The weight loss drug race has Amgen coming for Novo Nordisk and Eli Lilly

Read: Quartz

2024-03-24

Visualizations

Public companies per Ceo gender for Novo Nordisk

Datasets

rows

Stocks for Novo Nordisk

Source

This dashboard is based on data from: Twitter, YAHOO-FIN, YFINANCE

Updated: 1 day ago

License

This content can be used under the CC BY 4.0 license

Going further

We would recommend you have a look at connected dashboards:

Ozempic (semaglutide) injection for Type 2 Diabetes (company)

Wegovy (semaglutide) Injection 2.4 mg (company)

Germany (country)

Amgen (company)